Profile data is unavailable for this security.
About the company
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
- Revenue in USD (TTM)3.02bn
- Net income in USD491.70m
- Incorporated1923
- Employees10.60k
- LocationWest Pharmaceutical Services Inc530 Herman O. West DriveEXTON 19341United StatesUSA
- Phone+1 (610) 594-2900
- Fax+1 (800) 345-9800
- Websitehttps://www.westpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter International Inc | 11.02bn | -355.00m | 11.19bn | 38.00k | -- | 1.55 | 17.68 | 1.02 | -0.6925 | -0.6654 | 21.46 | 14.09 | 0.4618 | 3.14 | 6.08 | 290,078.90 | -1.48 | -0.8441 | -1.87 | -1.03 | 35.05 | 38.63 | -3.20 | -2.03 | 1.18 | 3.42 | 0.5684 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 1.60 |
| Revvity Inc | 2.86bn | 239.88m | 11.28bn | 11.00k | 48.05 | 1.56 | 17.49 | 3.95 | 2.07 | 2.08 | 24.49 | 63.95 | 0.2326 | 3.46 | 4.15 | -- | 1.95 | 3.23 | 2.13 | 3.58 | 54.77 | 58.48 | 8.40 | 13.58 | 1.40 | 5.23 | 0.3075 | 8.52 | 3.67 | -5.47 | -15.26 | -19.91 | -1.05 | 0.00 |
| Globus Medical Inc | 2.77bn | 423.78m | 11.71bn | 5.30k | 28.28 | 2.68 | 16.73 | 4.23 | 3.09 | 3.09 | 20.09 | 32.68 | 0.5441 | 1.29 | 4.59 | 522,604.50 | 8.32 | 4.70 | 9.53 | 5.18 | 65.34 | 66.40 | 15.30 | 9.73 | 2.47 | 15.96 | 0.0002 | 0.00 | 60.62 | 26.25 | -16.19 | -7.88 | 10.29 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 12.60bn | 20.95k | 31.04 | 3.11 | 30.73 | 3.12 | 5.66 | 5.66 | 55.58 | 56.43 | 0.6483 | 5.33 | 3.85 | -- | 6.59 | 8.11 | 9.67 | 11.97 | 68.25 | 70.40 | 10.17 | 12.31 | 1.24 | -- | -- | -- | 0.899 | 10.30 | -2.61 | -25.40 | -- | -- |
| Guardant Health Inc | 902.57m | -398.79m | 12.67bn | 2.00k | -- | -- | -- | 14.04 | -3.21 | -3.21 | 7.27 | -2.84 | 0.6411 | 4.02 | 8.85 | 451,510.30 | -28.33 | -24.20 | -33.49 | -26.83 | 63.76 | 63.23 | -44.18 | -91.24 | 3.12 | -10.70 | 1.47 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Solventum Corp | 8.40bn | 1.52bn | 13.35bn | 22.00k | 8.86 | 2.68 | 6.53 | 1.59 | 8.69 | 8.69 | 48.01 | 28.75 | 0.5851 | 3.85 | 7.91 | 381,909.10 | 10.61 | -- | 13.32 | -- | 54.18 | -- | 18.13 | -- | 1.14 | 1.76 | 0.5075 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
| Penumbra Inc | 1.33bn | 164.03m | 13.42bn | 4.50k | 82.53 | 9.85 | 73.95 | 10.06 | 4.14 | 4.14 | 33.63 | 34.70 | 0.8276 | 1.07 | 7.42 | 296,399.60 | 10.18 | 1.42 | 11.31 | 1.58 | 66.80 | 63.21 | 12.30 | 1.96 | 4.18 | -- | 0.0171 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 15.70bn | 15.00k | 42.75 | 1.90 | 20.87 | 3.84 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| West Pharmaceutical Services Inc | 3.02bn | 491.70m | 16.66bn | 10.60k | 34.32 | 5.46 | 25.86 | 5.52 | 6.75 | 6.75 | 41.41 | 42.44 | 0.7757 | 4.63 | 5.13 | 284,707.60 | 12.32 | 15.61 | 14.46 | 18.70 | 35.58 | 38.00 | 15.88 | 18.84 | 2.18 | -- | 0.0638 | 10.20 | -1.92 | 9.48 | -16.97 | 15.31 | 24.43 | 5.84 |
| Hologic Inc | 4.13bn | 543.80m | 16.68bn | 7.07k | 31.00 | 3.18 | 19.87 | 4.04 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.52bn | 246.20m | 17.10bn | 3.90k | 70.55 | 12.36 | 51.26 | 6.78 | 3.45 | 3.45 | 34.85 | 19.68 | 0.833 | 1.62 | 6.02 | 646,641.00 | 8.13 | 6.00 | 10.05 | 7.03 | 71.46 | 67.05 | 9.76 | 9.22 | 2.18 | 27.39 | 0.423 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
| Zimmer Biomet Holdings Inc | 8.01bn | 805.20m | 17.58bn | 17.00k | 21.96 | 1.38 | 9.35 | 2.20 | 4.04 | 4.04 | 40.22 | 64.36 | 0.3544 | 0.943 | 5.20 | 471,235.30 | 3.57 | 2.34 | 4.12 | 2.68 | 71.44 | 71.18 | 10.08 | 7.60 | 1.39 | 5.41 | 0.3886 | 37.52 | 3.85 | -0.7725 | -11.74 | 2.05 | -3.69 | 0.00 |
| Illumina Inc | 4.34bn | 850.00m | 20.42bn | 8.97k | 24.45 | 7.50 | 28.36 | 4.70 | 5.46 | 5.46 | 27.84 | 17.82 | 0.6709 | 2.61 | 5.41 | -- | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | -- | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -- | -- |
| Waters Corp | 3.11bn | 648.81m | 22.44bn | 7.60k | 34.68 | 9.63 | 26.35 | 7.22 | 10.87 | 10.87 | 52.02 | 39.15 | 0.6626 | 2.33 | 4.38 | 408,636.60 | 13.84 | 18.41 | 17.76 | 23.46 | 58.96 | 58.71 | 20.89 | 22.81 | 1.08 | 14.57 | 0.3765 | 0.00 | 0.0667 | 4.22 | -0.6851 | 1.61 | -2.75 | -- |
Data as of Feb 06 2026. Currency figures normalised to West Pharmaceutical Services Inc's reporting currency: US Dollar USD
40.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 8.83m | 12.27% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 3.79m | 5.27% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 3.21m | 4.46% |
| Artisan Partners LPas of 30 Sep 2025 | 2.77m | 3.85% |
| Walter Scott & Partners Ltd.as of 30 Sep 2025 | 2.41m | 3.35% |
| Brown Advisory LLCas of 30 Sep 2025 | 2.40m | 3.34% |
| Geode Capital Management LLCas of 30 Sep 2025 | 1.86m | 2.58% |
| Van Eck Associates Corp.as of 30 Sep 2025 | 1.42m | 1.98% |
| APG Asset Management NVas of 30 Sep 2025 | 1.41m | 1.97% |
| Durable Capital Partners LPas of 30 Sep 2025 | 1.17m | 1.63% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
